About Mission Leadership Partnerships News Contact
Contact
     
For questions about APS ACTION, please contact:

APS ACTION Lead Coordinator:
Joann Vega
Hospital for Special Surgery
535 E 70th Street
New York, NY
info@apsaction.org
(212) 774.2795
 

A Catalyst for Antiphospholipid
Syndrome Research

March 2011 - The treatment of the serious, potentially fatal autoimmune clotting disorder antiphospholipid syndrome (APS) has, in general, been empiric and based on various approaches to inhibit the clotting system.
Read More


Little-Studied Blood Syndrome Gains
Researchers' Attention

March 15, 2011 - Motivated by the lack of treatment options for patients with antiphospholipid syndrome (APS), rheumatology researchers convened an international committee to address the problem directly.
Read More


International Summit Held
to Stimulate Collaborative Clinical Research on Antiphospholipid Syndrome

November 2, 2010 - Antiphospholipid Syndrome (APS) is a condition that may be responsible for up to one-third of strokes in people under age 50, up to one-fifth of all cases of blood clots in large veins, and one-quarter of recurrent miscarriages.
Read More